Amphora Discovery Corporation has signed a research development deal with California-based Nanosyn.

Terms of the deal were not disclosed, although Nanosyn received an upfront fee and will receive research funding as well as milestone payments based on the success of the collaboration between the two companies.

Amphora is already developing two compounds with Nanosyn, which is providing chemistry-based services.

Amphora has a variety of compounds under development targeting oncology and inflammation.